{"nct_id":"NCT03357952","title":"A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2017-11-16","start_date_type":"ACTUAL","primary_completion_date":"2018-10-24","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-19","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["JNJ"]}